Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportCardiovascular: Basic Science

Cardiac imaging and uptake mechanism of 18F LMI1195, a novel PET cardiac neuronal imaging agent

Melanie Lamoy, Jody Bozek, Mania Kavosi, Padmaja Yalamanchili, Mikhail Kagan, Michael Azure, Simon Robinson and Ming Yu
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 262;
Melanie Lamoy
1Lantheus Medical Imaging, N Billerica, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jody Bozek
1Lantheus Medical Imaging, N Billerica, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mania Kavosi
1Lantheus Medical Imaging, N Billerica, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Padmaja Yalamanchili
1Lantheus Medical Imaging, N Billerica, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mikhail Kagan
1Lantheus Medical Imaging, N Billerica, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Azure
1Lantheus Medical Imaging, N Billerica, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon Robinson
1Lantheus Medical Imaging, N Billerica, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ming Yu
1Lantheus Medical Imaging, N Billerica, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

262

Objectives Imaging with 123I-meta-iodobenzylguanidine (MIBG) was shown to predict heart failure progression, but the image quality is poor. Like MIBG, LMI1195 is designed as a substrate for norepinephrine transporter (NET), but labeled with 18F to take advantages of PET technology. This study evaluated cardiac image quality of LMI1195 and its affinity and selectivity to NET and uptake kinetics, in comparison with norepinephrine (NE).

Methods The affinity (Ki) was determined in a competition binding assay by incubating 19F-LMI1195, a cold analog of LMI1195, or NE with 3H-desmethylimipramine in cell membrane overexpressing human NET. The uptake selectivity was assessed by measuring LMI1195 or 3H-NE cell uptake with and without pretreatment of desipramine, a selective NET inhibitor, in SK-N-SH (human neuroblastoma) and PC-12 (rat pheochromocytoma) cells. In SK-N-SH cells, the uptake kinetics (Km and Vmax) was evaluated by measuring NET mediated uptake of 19F-LMI1195 or NE at various concentrations. LMI1195 cardiac image quality was evaluated by PET imaging (~1.5 mCi, i.v.) in rabbits in the presence and absence of desipramine (1 mg/kg).

Results In competition binding assays, Ki values for LMI1195 and NE were similar (5.2±1.1 and 3.4±1.3µM). In cell studies, blockade of NET inhibited LMI1195 and NE uptake by 66±7 and 93±1% in PC-12 cells, and 91±1 and 97±1% in SK-N-SH cells. In SK-N-SH cells, Km and Vmax values for LMI1195 were 1.4±0.3 µM and 6.0±1.3pMol/million cells/min similar to that of NE (2.0±0.4µM and 6.2±0.7pMol/million cells/min). Moreover, LMI1195 cell uptake was inhibited by 19F-LMI1195 or NE in a concentration-dependent manner. Imaging in rabbits with LMI1195 showed clear myocardium uptake with low liver activity. Cardiac uptake could be inhibited by desipramine.

Conclusions The cell uptake profile of LMI1195 is similar to NE with high selectivity. Cardiac images of LMI1195 are clear and the heart uptake is mediated by NET

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 51, Issue supplement 2
May 2010
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cardiac imaging and uptake mechanism of 18F LMI1195, a novel PET cardiac neuronal imaging agent
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Cardiac imaging and uptake mechanism of 18F LMI1195, a novel PET cardiac neuronal imaging agent
Melanie Lamoy, Jody Bozek, Mania Kavosi, Padmaja Yalamanchili, Mikhail Kagan, Michael Azure, Simon Robinson, Ming Yu
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 262;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cardiac imaging and uptake mechanism of 18F LMI1195, a novel PET cardiac neuronal imaging agent
Melanie Lamoy, Jody Bozek, Mania Kavosi, Padmaja Yalamanchili, Mikhail Kagan, Michael Azure, Simon Robinson, Ming Yu
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 262;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Cardiovascular: Basic Science

  • The performance of phase analysis in the presence of perfusion defects
  • Roles of cardiac norepinephrine uptake 1 and 2 in evaluation of LMI1195, a new cardiac PET neuronal imaging agent, in rats, rabbits and nonhuman primates
  • Preparation and evaluation of a 99mTc-labeled rhodamine-conjugated angiotensin peptide as a cardiac function imaging agent
Show more Cardiovascular: Basic Science

Cardiovascular Basic PET

  • Stable delineation of the ischemic area by the novel PET perfusion tracer F-18-fluorobenzyl triphenyl phosphonium (FBnTP) after transient coronary occlusion
  • Small animal PET imaging of myocardial PDE4 with (R)-[11C]rolipram in rats
Show more Cardiovascular Basic PET

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire